Kaposi virus scores cancer coup

Nature Medicine

Volumn 9, Issue 3, 2003, Pages 261-262

  Boshoff, Chris ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL NUCLEUS ANTIGEN; CYCLINE; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 6; ONCOPROTEIN; WNT PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARCINOGENESIS; COMPLEX FORMATION; GENE EXPRESSION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOCYTE PROLIFERATION; NONHUMAN; ONCOVIRINAE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS ONCOGENE;

ANTIGENS, VIRAL; BETA CATENIN; CELL NUCLEUS; CYTOSKELETAL PROTEINS; GLYCOGEN SYNTHASE KINASE 3; HERPESVIRUS 8, HUMAN; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NUCLEAR PROTEINS; ONCOGENES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VIRUS LATENCY; WNT PROTEINS; ZEBRAFISH PROTEINS;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; ONCOVIRINAE;

EID: 0037348197     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0303-261     Document Type: Short Survey

References (11)

1. Chang, Y. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869 (1994).
2. Boshoff, C. & Weiss, R.A. AIDS-related malignancies. Nat. Rev. Cancer 2, 373-382 (2002).
3. Fujimuro, M. et al. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9, 300-306 (2003).
4. Polakis, P. Wnt signaling and cancer. Genes Dev. 14, 1837-1851 (2000).
5. Kielman, M.F. et al. Apc modulates embryonic stemcell differentiation by controlling the dosage of β-catenin signaling. Nat. Genet. 32, 594-605 (2002).
6. Ballestas, M.E., Chatis, P.A. & Kaye, K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644 (1999).
7. Friborg, J., Kong, W., Hottiger, M.O. & Nabel, G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894 (1999).
8. Radkov, S.A., Kellam, P. & Boshoff, C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121-1127 (2000).
9. Verschuren, E.W., Klefstrom J., Evan, G.I. & Jones, N. The oncogenic potential of Kaposi's sarcoma associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2, 229-241 (2002).
10. Bais, C. et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86-89 (1998).
11. Montaner, S. et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3, 23-36 (2002).